Navigation Links
Biopsies Of Human Skin And Bone Marrow Support T Cell Development

Recent research suggests that biopsies of human skin and bone marrow can provide the basis for the generation of a new, patient-specific T cell repertoire. T cells generated in skin cell cultures are diverse, mature, functional, and tolerant to self-MHC//.

T cells play a central role in the human adaptive immune system, discriminating self from non-self, directing less specific elements of the immune system in the performance of effector functions, and serving as a repository for immunologic memory.

The ability to generate T cells suitable for use in human patients could lead to significant advances in the treatment of immunodeficiencies and malignancies. Such therapies have not yet been realized because the unique requirements for T cell development are difficult to replicate in vitro.

The authors, writing in the November issue of The Journal of Clinical Investigation report that fibroblasts and keratinocytes from human skin arrayed on a synthetic 3-dimensional matrix support the development of functional human T cells from hematopoietic precursor cells in the absence of thymic tissue.

The researchers from Harvard Skin Disease Research Center and Department of Dermatology, Brigham and Women’s Hospital, Harvard Institutes of Medicine, Boston, Massachusetts, USA, found that newly generated T cells contained T cell receptor excision circles, possessed a diverse T cell repertoire, and were functionally mature and tolerant to self MHC, indicating successful completion of positive and negative selection.

Skin cell cultures expressed three transcription factors and a panel of autoantigens.

The authors conclude that skin and bone marrow biopsies can thus be used to generate de novo functional and diverse T cell populations for potential therapeutic use in immunosuppressed patients.


'"/>




Page: 1

Related medicine news :

1. More Accurate "PROSTATE CANCER" Test can save Unnecessary Biopsies
2. eSie Touch Elasticity Imaging, and a Promise of Avoiding Breast Biopsies
3. MRI-safe Motor Makes Robotic Biopsies Possible
4. MRI Robotic Biopsies Simplified by PneuStep
5. Human Genome Project Achieves Technological Triumph
6. First Vaccine Designed for Africa Cleared for Testing in Humans
7. Human gene number increases
8. Scientists found ancient Human Germ Killer
9. New standards for Human Research Safety
10. Human wasting disease linked to a gene
11. The Human Mad Cow Case
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... June 23, 2017 , ... Ulster University, Magee Campus ... from 9 am to 3 pm to present to graduate students exciting new and ... an original curriculum project led by The Health Improvement Service of the Western Health ...
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, ... families and business owners in North Central West Virginia, is embarking on a ... differently abled residents in the region. , The Stepping Stones organization offers a ...
(Date:6/22/2017)... Indianapolis, IN (PRWEB) , ... June 22, 2017 ... ... employee benefits advisory organization, is pleased to welcome Whipple & Company as its ... on the clear purpose of balancing their clients’ risk while tailoring optimized benefit ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... awards for environmental excellence. Maryland Recycling Network has awarded the Baltimore VA Medical ... Outstanding Small Government Program Award for its efforts to promote waste reduction and ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... that Claritas Capital, a Nashville-based private equity firm, has invested $3.35 million in ... for some time, and Claritas Capital offers the smart money, speed to market ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 8, 2017  Less than a month ago, amateur ... 200,000 companies, including hospital networks, in over 150 countries. ... of the largest online extortion attempts ever recorded. With ... it is imperative that providers understand where the risks ... this — and many other very real cyber threats.  ...
(Date:6/7/2017)... GAITHERSBURG, Md. , June 7, 2017  Novavax, Inc., ... the second of two Phase 2 trials of its RSV ... women of child bearing age have been published in the ... this publication have been shared in prior scientific conferences). The ... trial in April 2014. Novavax is developing the RSV F ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
Breaking Medicine Technology: